HCA Healthcare’s (HCA) Neutral Rating Reiterated at JPMorgan Chase & Co.

JPMorgan Chase & Co. reissued their neutral rating on shares of HCA Healthcare (NYSE:HCA) in a report published on Tuesday, MarketBeat reports. The firm currently has a $380.00 price target on the stock.

Several other research analysts also recently weighed in on the company. Royal Bank of Canada increased their price target on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their target price for the company from $400.00 to $320.00 in a report on Monday, November 25th. KeyCorp decreased their price objective on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Finally, Raymond James lowered HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. One analyst has rated the stock with a sell rating, four have given a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $385.63.

HCA Healthcare Trading Down 0.5 %

Shares of HCA stock opened at $297.52 on Tuesday. The company has a 50 day moving average of $348.93 and a 200-day moving average of $357.51. HCA Healthcare has a 12-month low of $263.22 and a 12-month high of $417.14. The firm has a market cap of $75.36 billion, a P/E ratio of 13.36, a PEG ratio of 1.21 and a beta of 1.63. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.89%. HCA Healthcare’s dividend payout ratio is 11.85%.

Insiders Place Their Bets

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Institutional Trading of HCA Healthcare

Several large investors have recently modified their holdings of the business. Unique Wealth Strategies LLC purchased a new position in shares of HCA Healthcare during the second quarter valued at approximately $28,000. Legacy Investment Solutions LLC bought a new stake in HCA Healthcare during the 3rd quarter valued at approximately $39,000. Capital Performance Advisors LLP bought a new position in shares of HCA Healthcare in the 3rd quarter worth approximately $41,000. Benjamin F. Edwards & Company Inc. purchased a new stake in HCA Healthcare in the second quarter worth $33,000. Finally, Canoe Financial LP purchased a new position in HCA Healthcare during the third quarter valued at $41,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.